CClinicalTrials.gg
TerminatedNCT02355366Updated Jan 22, 2019

Family Focused Therapy for Teens at Risk for Bipolar Disorder

An interventional study of Family-Focused Therapy and Brief Educational Treatment in Bipolar Disorder, sponsored by Sunnybrook Health Sciences Centre. Terminated at 1 site in Canada. Open to participants aged 13 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-22.

Sponsored by Sunnybrook Health Sciences Centre · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
13 Years to 19 Years
Sex
All
01

Study summary

The present study aims to examine the effects of a 4 month, family focused therapy (FFT) intervention on the 1 year course of mood symptoms in offspring of parents with bipolar disorder (BD). The study will also examine the level of expressed emotion among families and how this impacts on FFT treatment outcomes. This study seeks to replicate a previous study by Miklowitz, Schneck, Singh, Taylor, George and colleagues (2013), which demonstrated the efficacy of FFT among BD offspring. Importantly, the present study will introduce biological measures that predict and reflect improvement in symptoms and expressed emotion. These markers reflect stress-related biological systems and include saliva samples to ascertain cortisol, interleukin-6 (IL-6) and salivary alpha amylase (sAA).

Read the detailed description

Children of parents with bipolar disorder (BD) have increased risk of developing BD themselves. BD in youth is associated with increased risk for suicidality, psychosis, substance abuse and compromised psychosocial functioning. In addition, offspring of parents with BD have an increased vulnerability for developing other psychopathology (e.g. major depression). At present, research examining early intervention and treatment for this high risk population is limited. However, a recent study in symptomatic youth at risk for BD indicated that participation in a family focused therapy (FFT) intervention led to positive treatment outcomes. The present study aims to examine the effects of FFT in BD offspring in comparison to a brief educational treatment. Specifically, this study will examine whether FFT can have protective effects on individuals' mood symptoms and functioning by targeting the family environment. We will expand upon previous research by also measuring biological markers of stress (i.e., cortisol levels) and changes in family functioning over time. With this knowledge, the results of this study may help to shed light on the importance of early intervention and improve preventative treatment options for youth at high-risk for bipolar disorder.

02

Conditions studied

  • Bipolar Disorder

Browse trials for

Keywords

  • Offspring
  • significant mood symptoms
03

In context

Bipolar Disorder

1,601 studies on the registry are indexed under Bipolar Disorder; 254 are open to participants now.

This study's enrollment of 2 is below the median of 64 across 1,223 interventional studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

Sunnybrook Health Sciences Centre is the lead sponsor of 566 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. English-speaking males and females of any race/ethnicity
  2. 13-19 years of age
  3. Have at least 1 biological parent who meets diagnostic criteria for bipolar disorder (BD) type I or II, based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
  4. Adolescent is experiencing current, significant mood symptoms indicated by a psychiatric status rating (PSR) score of 3
  5. At least 1 parent/primary caregiver is available to attend sessions.

All participants will complete rigorous diagnostic interviews to ensure that they meet these requirements.

Exclusion criteria

Exclusion Criteria:

  1. Unable to provide informed consent (e.g., severe psychosis, developmental delay)
  2. Have met the DSM-IV criteria (based on the Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Life Version - K-SADS-PL), for substance dependence in the past 3 months (excluding nicotine dependence)
  3. Are victims of current sexual or physical abuse by parents or live among domestic violence
  4. For offspring, already meet criteria for bipolar disorder (BD) type I or II.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
2 participants (actual)

Study arms

  • Experimental
    Family Focused Therapy (FFT)

    Participants will receive Family-Focused Therapy (FFT). It will consist of twelve, 1-hour long sessions, over a period of 4 months. The 12 sessions will include psychoeducation (sessions 1-4), training in communication enhancement (sessions 5-8) and training in relation to problem-solving skills (sessions 9-12).

    Behavioral: Family-Focused Therapy

  • Active comparator
    Brief Educational Treatment

    Participants will be receive 1-2 educational sessions which will include diagnostic feedback, recommendations for further treatment and crisis intervention if required.

    Behavioral: Brief Educational Treatment

Interventions

  • BehavioralFamily-Focused Therapy

    Family Focused Therapy is a manual-based, psycho-educational intervention which is designed to reduce intra-familial stress, conflict, and affective arousal by enhancing communication and problem solving skills among families who are affected by bipolar disorder (Miklowitz et al., 2013). It concentrates on skills relevant to managing the prodromal stages of bipolar disorder, such as mood monitoring, reducing family conflict, improving problem solving, stabilizing daily routines and regulating sleep/wake cycles (Miklowitz, 2012).

    Also known as: FFT, Family Therapy, Psychosocial Intervention, Psychoeducaton, Psychotherapy, Behaviour Therapy

  • BehavioralBrief Educational Treatment

    Brief Educational Treatment will consist of 1 - 2 sessions involving both parents and adolescents; it will consist of diagnostic feedback following the adolescent's baseline assessment. It will provide families with information and strategies on tracking and managing adolescent mood disorders. Additionally, ongoing medication management and crisis family sessions will be available if required.

    Also known as: Psychoeducation, Diagnostic Evaluation, Crisis Management

06

What researchers measure

Primary outcomes

  1. KSADS Mania Rating Scale (KMRS)

    Measures symptom severity.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  2. KSADS Depression Section (KDRS)

    Measures symptom severity.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  3. Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE)

    Used to track symptom severity, treatment (both psychosocial and psychotropic), self-injurious/suicidal behavior and psychosocial functioning over time.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  4. The Family Environment Scale (FES)

    Examines each family member's perceptions of the family in three ways-as it is (real), as it would be in a perfect situation (ideal) and as it will probably be in new situations (expected).

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  5. Family Adaptability & Cohesion & Adaptability Scale (FACES)

    Evaluate the adaptability and cohesion dimensions in family interactions.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  6. Conflict Behaviour Questionnaire (CBQ)

    Measures conflict and negative communication between parents and adolescents.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  7. Issues Checklist

    Measures potential areas of conflict between parents and adolescents.

    Time frame: Change from baseline to endpoint (assessed at 0, 4 and 12 months)

  8. Cortisol

    Stress-related biomarker obtained through saliva samples.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)

  9. Interleukin 6 (IL-6)

    Stress-related biomarker obtained through saliva samples.

    Time frame: Change from baseline to endpoint (assessed at weeks 0, 4, and 12 months)

  10. Alpha Amylase

    Stress-related biomarker obtained through saliva samples.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)

  11. Five Minute Speech Sample

    Assesses level of expressed emotion (EE) within the parental household.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)

  12. Emotional Response to Conflict Scale (ERCS)

    Assesses individuals' emotional responses to a brief, laboratory based, conflict negotiation task.

    Time frame: Change from baseline to endpoint (assessed at 0, 4 and 12 months)

Secondary outcomes

  1. Children Global Assessment Scale

    Quantifies overall level of functioning for a child or adolescent during a specified time period.

    Time frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)

  2. Anthromorphic Data

    Measures height, weight, body mass index, \& blood pressure.

    Time frame: Change from baseline to endpoint (Assessed at weeks 0 and 12 months)

  3. Working Alliance Inventory Short-Revised (WAI-SR)

    Measures therapeutic alliance.

    Time frame: Change from baseline to endpoint. For FFT Group: Assessed after therapy sessions 1, 4, 8 & 12. For Education Control Group: Assessed after therapy sessions 1 & 2.

  4. General Information Sheet

    Demographics

    Time frame: Baseline

07

Study locations

1 site
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
08

References and documents

Publications

  • Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, Howe ME, Dickinson LM, Garber J, Chang KD. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb;52(2):121-31. doi: 10.1016/j.jaac.2012.10.007. Epub 2013 Jan 2. PubMed 23357439 ↗
  • Miklowitz DJ. Family-focused treatment for children and adolescents with bipolar disorder. Isr J Psychiatry Relat Sci. 2012;49(2):95-101. PubMed 22801288 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02355366
Lead sponsor
Sunnybrook Health Sciences Centre
Responsible party
Dr. Benjamin Goldstein (Associate Professor, University of Toronto, Sunnybrook Health Sciences Centre) — Principal investigator
First posted
Feb 4, 2015
Start date
Apr 2015
Primary completion
Nov 26, 2018
Completion
Nov 26, 2018
Last update
Jan 22, 2019

Study contacts

Benjamin Goldstein, MD
principal investigator · Sunnybrook Health Sciences Centre

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion